Search Results

Displaying Results 1126-1150 of 7540 "'RARE'"

Jul 20, 2026, 17:58 ET Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Kinase AMP-activated non-catalytic subunit Gamma 2) syndrome and ATR 1086 for PLN (phospholamban) cardiomyopathy, and two undisclosed research targets in rare cardiomyopathies.For more information about our RNA delivery platform, development pipeline and people, please visit

More news about: Atrium Therapeutics


Jul 20, 2026, 16:15 ET Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026

purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease — often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies,

More news about: Jazz Pharmaceuticals plc


Jul 20, 2026, 15:00 ET Embry-Riddle and Former NTSB Chairman Robert Sumwalt Launch 'Safer Skies' Video Podcast to Explore Innovations Behind Aviation and Aerospace Safety

to the industry's rigorous safety standards and advanced safety across the globe."Produced by BCAAS, each consumable, 30-minute episode offers rare insight into the experiences of industry experts, the practices that ensure the safety of all who fly, and the ideas that are shaping the future of

More news about: Embry-Riddle Aeronautical University


Jul 20, 2026, 13:38 ET In HelloNation, Insurance Expert James Vandespyker Explains Personal Articles Insurance

scheduling an item requires documentation. Most insurers request specific details, including serial numbers, condition, or brand information. For jewelry and rare collectibles, an insurance appraisal is often needed to determine value and create a record. In other cases, receipts and photographs may be enough

More news about: HelloNation


Jul 20, 2026, 13:28 ET World-Premier Cancer Center Sheba Medical Center Selects Entolimod for Clinical Trial, Potentially Expanding Valion Bio into the Multi-Billion-Dollar Neutropenia Market

protocol at Sheba Medical Center, one of the world's leading hospitals, to evaluate Entolimod in cancer patients receiving high doses of irradiation for a rare form of cancer.

More news about: Valion Bio, Inc.


Jul 20, 2026, 13:04 ET Jaguar Uranium Reports Preliminary Surface Sampling Results from Huemul Uranium-Copper-Vanadium Project

Berlin Project in Caldas Province, Colombia is a district-scale, sedimentary-hosted polymetallic system historically reported to host uranium alongside rare earth elements, vanadium, nickel, phosphate, molybdenum, rhenium and zinc. Jaguar completed a $25 million initial public offering on NYSE American in

More news about: Jaguar Uranium Corp.


Jul 20, 2026, 12:33 ET Swiss Hill Advisors Celebrates More Than a Decade as a Specialized Force in Alternative Investment Advisory

durable relationships on both sides of the capital formation equation.Together, Lieberman and Mettel bring a combination of capabilities that is rare in the placement agent landscape, including deep expertise in complex credit and specialty finance structures, direct experience on both the buy side

More news about: Swiss Hill Advisors


Jul 20, 2026, 11:36 ET Interlune Produces Pure Helium-3 from Domestic Helium Using Novel Cryogenic Technology

critical isotope for use in quantum computing. Helium-3 is strategically important for national defense and advanced computing applications, but extremely rare on Earth.

More news about: Interlune


Jul 20, 2026, 11:00 ET ARUP Launches First Clinical Spectral Flow Cytometry Assay for MRD Assessment in Multiple Myeloma

neoplastic cells in a population of 5 million analyzed cells with 95% confidence, Ng said."We see large volumes with high complexity cases, including rare diseases," said Tracy George, MD, ARUP chief scientific officer and president of the Innovation Business Unit. "This ensures not only the breadth and

More news about: ARUP Laboratories


Jul 20, 2026, 11:00 ET MCCATHERN, SHOKOUHI, EVANS LAUNCHES DEBUT PODCAST, "THE LAW BEHIND THE HEADLINES"

HERE"The Law Behind the Headlines" showcases a rare glimpse into the mindset behind the world's most famous legal cases. The podcast isn't your average legal content – episodes feature hot-topic legal

More news about: McCathern Law


Jul 20, 2026, 09:52 ET FETV Strikes It Rich with The Beverly Hillbillies

"The Beverly Hillbillies is one of those rare sitcoms that is just as funny today as it was more than 60 years ago," said Adam Sumrall, Executive Vice President of FETV and FMC. "If you know the

More news about: FETV


Jul 20, 2026, 09:44 ET DJI Matrice 4E et DJI Terra cartographient la cascade de glace du Khumbu pendant la saison d'ascension 2026 sur le mont Everest

glace n'ont plus besoin d'y pénétrer à l'aveugle. Cela s'est révélé crucial pendant la saison d'escalade 2026. Du jour au lendemain, un champ de séracs rare et de grande ampleur s'est formé sur l'icefall, bloquant toutes les voies vers le sommet. Des centaines d'alpinistes se sont retrouvés bloqués au camp

More news about: DJI


Jul 20, 2026, 09:29 ET DJI Matrice 4E and DJI Terra Map Khumbu Icefall During 2026 Climbing Season on Mount Everest

single day. Moreover, icefall doctors no longer need to enter the icefall blind.  This proved critical during the 2026 climbing season. Overnight, a rare, large-scale serac field formed across the icefall, sealing every route to the summit. Hundreds of climbers were stranded at Base Camp. Fortunately,

More news about: DJI


Jul 20, 2026, 09:00 ET Argo Biopharma Doses First Participant in Phase I Clinical Trial of Factor XI Targeting siRNA Therapy BW-41012

molecule candidates targeting a wide range of indications, including cardiovascular diseases, viral infections, metabolic conditions, and specialty/rare diseases. Currently, Argo Biopharma has eight RNAi candidates in clinical development.For more information, please visit

More news about: Argo Biopharmaceutical Co., Ltd


Jul 20, 2026, 08:35 ET Tom Ruggie Earns Back-to-Back InvestmentNews Advisor of the Year Honors for Alternative Investments

and CEO of Destiny Family Office, has been named InvestmentNews 2026 Advisor of the Year, Alternative Investments for the second consecutive year, a rare distinction that reflects his continued leadership in expanding access to privileged private investments and serving the increasingly complex needs

More news about: Destiny Family Office


Jul 20, 2026, 08:26 ET RMX Appoints John Scott to Advisory Board

Scott. "I believe the potential for RMX to drive meaningful impact at both the state and national level is enormous.""John brings a rare combination of leadership, integrity, and deep insight into how enterprise and government operate," said Karl Kit, CEO of RMX. "His appointment signals

More news about: RMX Industries, Inc.


Jul 20, 2026, 08:08 ET FAST Awards Grant to Nobel Laureate Frances Arnold to Advance Next-Generation Tools for a Novel Therapeutic Strategy for Angelman Syndrome

nucleoside analogs with properties that may be useful to target the UBE3A antisense (UBE3A-ATS) transcript.Angelman syndrome (AS) is a rare neurogenetic disorder caused by the loss of function of the maternally inherited UBE3A gene. It can cause significant developmental delays, motor

More news about: AS2Bio


Jul 20, 2026, 08:00 ET An Iconic New Fragrance for a New Generation

White Diamonds fragrance in 1991. In 2013, he became the first perfumer in IFF's history to be named Master Perfumer, a distinction that speaks to his rare gift for compositions that are, as he describes them, imaginative and harmonious in equal measure. Senior Perfumer Catapano Côté-Mouzannar, whose work

More news about: Revlon


Jul 20, 2026, 08:00 ET Generative Bionics Introduces Gene.01, a Fully Functional Smart-Skin Humanoid Robot Platform Designed for Safe Human Collaboration

AI computing can quickly turn long-standing scientific research into a market-ready industrial humanoid. The platform is built by an expert team with rare depth in humanoid robotics and industrial execution. Nearly half of Generative Bionics' 100-person team hold PhDs and bring more than 15 years of experience

More news about: Generative Bionics


Jul 20, 2026, 07:37 ET YY Group Appoints Former Changi Airport Executive Ng Yansheng as Managing Director of YY Circle (SG) Pte. Ltd. to Drive Next Phase of Growth

transformation makes him the ideal leader for our Singapore operations," said Mike Fu, Chairman and Chief Executive Officer of YY Group. "He brings a rare blend of strategic foresight and operational rigor. We are thrilled to welcome him aboard as YY Circle Singapore continues to scale."Commenting

More news about: YY Group Holding Limited


Jul 20, 2026, 07:30 ET Biohaven to Present New Clinical Data at ESMO Congress on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload

clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today announced that new data on BHV-1530, its FGFR3-directed antibody-drug conjugate (ADC) using a novel topoisomerase I (TopoIx)

More news about: Biohaven Ltd.


Jul 20, 2026, 07:00 ET BioLineRx and Hemispherian AS to Present Data Demonstrating Strong Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancers at ESMO 2026

/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Hemispherian AS, a clinical-stage oncology company developing novel small molecule therapeutics, today announced that an abstract featuring

More news about: BioLineRx; Hemispherian AS


Jul 20, 2026, 06:50 ET Jaguar Uranium Reports Preliminary Surface Sampling Results from Huemul Uranium-Copper-Vanadium Project

Berlin Project in Caldas Province, Colombia is a district-scale, sedimentary-hosted polymetallic system historically reported to host uranium alongside rare earth elements, vanadium, nickel, phosphate, molybdenum, rhenium and zinc. Jaguar completed a $25 million initial public offering on NYSE American in

More news about: Jaguar Uranium


Jul 20, 2026, 06:00 ET LIMITED TICKETS AVAILABLE FOR "AN EVENING WITH DAVID LETTERMAN AND SPECIAL GUEST WILL ARNETT" AT MONTREAL'S JUST FOR LAUGHS

follows his sold-out appearance at Just For Laughs Vancouver earlier this year, his first Canadian performance since 1978, and offers audiences another rare opportunity to experience the legendary host live on stage.Tickets are available at

More news about: Just For Laughs


Jul 20, 2026, 03:46 ET Lundbeck announces last patient randomized in DEEp OCEAN, a large Phase III trial in developmental and epileptic encephalopathies (DEEs)

period followed by the optional open-label extension.About DEEsDevelopmental and Epileptic Encephalopathies (DEEs) are a group of rare neurodevelopmental disorders that typically manifest in early childhood.1 These heterogeneous and severe epilepsy syndromes are characterized

More news about: H. Lundbeck A/S


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.